Heart Attack
Increasing elastin within myocardial scars shows benefit
Published in Vaccine Weekly, November 2nd, 2005
According to recent research from Canada, "After a myocardial infarction, the injured region becomes fibrotic and the myocardial scar may expand if the ventricular wall lacks elasticity. Cardiac dilatation may precipitate the vicious cycle of progressive heart failure."
T. Mizuno and associates at the University of Toronto explained, "The present study evaluated the functional benefits of increasing elastin within a myocardial scar using cell based gene therapy. A myocardial infarction was generated by ligation of the left...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-11-02)
More Articles from Vaccine Weekly
- Cancer Vaccine Development
Cancer immunotherapy targeting sperm protein 17 looks promising - Cancer Vaccine Development
Efficacy of cancer vaccine improved by manipulating cell trafficking - Leukemia
Benzodithiophenes induced differentiation and apoptosis in human leukemia cells - Multiple Sclerosis Vaccine Development
Highly immunogenic peptide vaccine for multiple sclerosis developed - Vaccine Policy
Immunocompetent travelers rarely require hepatitis A or B booster shots - Adverse Drug Reaction
Agencies issue alert on Menactra meningococcal vaccine and Guillain Barre syndrome - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
